Tamoxifen delays the development of resistance to cisplatin in human melanoma and ovarian cancer cell lines.

The development of resistance to cisplatin (DDP) occurs rapidly both in vitro and in vivo, and constitutes a major obstacle to effective therapy. We have previously demonstrated that there is a highly synergistic interaction between tamoxifen (TAM) and DDP against cell lines representative of three...

Descripción completa

Detalles Bibliográficos
Autores principales: McClay, E. F., Albright, K. D., Jones, J. A., Christen, R. D., Howell, S. B.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1994
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033375/
https://www.ncbi.nlm.nih.gov/pubmed/8080729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033375/
https://www.ncbi.nlm.nih.gov/pubmed/8080729

Ejemplares similares